Variables | All Subjects (n = 116) | Survive (n = 67) | Died (n = 49) | P value |
---|---|---|---|---|
Age, mean ± SD | 54 ± 13.01 | 53 ± 12.48 | 55 ± 13.69 | 0.306 |
Age, n (%) | ||||
< 60 years | 75 (64.7) | 45 (67.2) | 30 (61.2) | - |
≥ 60 years | 41 (35.3) | 22 (32.8) | 19 (38.8) | 0.662 |
Sex, n (%) | ||||
Female | 32 (27.6) | 18 (26.9) | 14 (28.6) | - |
Male | 84 (72.4) | 49 (73.1) | 35 (71.4) | 0.971 |
Comorbidity | ||||
Diabetes Mellitus, n (%) | ||||
No | 83 (71.6) | 46 (68.7) | 37 (75.5) | - |
Yes | 33 (28.4) | 21 (31.3) | 12 (24.5) | 0.549 |
Hypertension, n (%) | ||||
No | 100 (86.2) | 56 (83.6) | 44 (89.8) | - |
Yes | 16 (13.8) | 11 (16.4) | 5 (10.2) | 0.493 |
Acute Kidney Injury, n (%) | ||||
No | 110 (94.8) | 63 (94.0) | 47 (95.9) | - |
Yes | 6 (5.2) | 4 (6.0) | 2 (4.1) | 0.977 |
Chronic Kidney Disease, n (%) | ||||
No | 110 (94.8) | 64 (95.5) | 46 (93.9) | - |
Yes | 6 (5.2) | 3 (4.5) | 3 (6.1) | 1.000 |
Stroke, n (%) | ||||
No | 113 (97.4) | 65 (97.0) | 48 (98.0) | - |
Yes | 3 (2.6) | 2 (3.0) | 1 (2.0) | 1.000 |
Etiology, n (%) | ||||
Unspecified NBNC | 7 (6) | 4 (6) | 3 (6.1) | - |
Autoimmune | 2 (1.7) | 1 (1.5) | 1 (2) | 0.858 |
Alcoholic | 4 (3.4) | 3 (4.5) | 1 (2) | 0.558 |
MAFLD | 24 (20.7) | 17 (25.4) | 7 (14.3) | 0.499 |
NASH | 2 (1.7) | 2 (3.0) | 0 (0) | 0.999 |
Primary biliary cirrhosis | 5 (4.3) | 1 (1.5) | 4 (8.2) | 0.216 |
HBV | 39 (33.6) | 24 (35.8) | 15 (30.6) | 0.826 |
HCV | 33 (28.4) | 15 (22.4) | 18 (36.7) | 0.576 |
Child-Pugh score, mean ± SD | 8 ± 2.73 | 7 ± 2.05 | 11 ± 2.05 | < 0.001 |
Child-Pugh class, n (%) | ||||
A | 31 (26.7) | 30 (44.8) | 1 (2.0) | - |
B | 36 (31.0) | 26 (38.8) | 10 (20.4) | 0.027 |
C | 49 (42.2) | 11 (16.4) | 38 (77.6) | < 0.001 |
MELD score, mean ± SD | 18 ± 9.73 | 12 ± 5.09 | 26 ± 8.69 | < 0.001 |
MELD, n (%) | ||||
< 14 | 51 (44.0) | 46 (68.7) | 5 (10.2) | - |
≥ 14 | 65 (56.0) | 21 (31.3) | 44 (89.8) | < 0.001 |
AST, U/L, median (min-max) | 53 (12–1927) | 43 (12–226) | 72 (25–1927) | < 0.001 |
ALT, U/L, median (min-max) | 32 (6–509) | 26 (9–121) | 39 (6–509) | 0.049 |
Hemoglobin, g/dl, mean ± SD | 9.53 ± 2.15 | 9.82 ± 2.20 | 9.12 ± 2.03 | 0.084 |
Platelet, x 103/mm3, mean ± SD | 110.1 ± 70.83 | 106 ± 63.07 | 114 ± 80.71 | 0.541 |
Leukocytes, x 103/mm3, median (min-max) | 8.1 (1.2–55.9) | 5.1 (1.2–39.0) | 15.1 (1.6–55.9) | < 0.001 |
Leukocytes, n (%) | ||||
< 12.000 | 81 (69.8) | 61 (91) | 20 (40.8) | - |
≥ 12.000 | 35 (30.2) | 6 (9) | 29 (59.2) | < 0.001 |
Albumin | 2.66 (1.22–4.17) | 2.94 (1.79–4.17) | 2.43 (1.22–3.44) | < 0.001 |
Bilirubin | 2.16 (0.36–38.36) | 2.1 (0.4–15.6) | 6.6 (0.4–38.4) | < 0.001 |
Protrombin time | 13.4 (10.6–120.0) | 12.7 (10.6–16.5) | 15.9 (10.9–120.0) | < 0.001 |
INR | 1.26 (0.96–11.76) | 1.21 (0.96–1.53) | 1.47 (1.04–11.76) | < 0.001 |
Ureum | 48.6 (9.6–458) | 31 (9.6–162) | 83 (24–458) | < 0.001 |
Creatinine | 0.9 (0.28–8.10) | 0.9 (0.4–3.6) | 1.2 (0.3–8.1) | < 0.001 |
Length of stay | 6 (1–34) days | 6 (1–26) days | 7 (1–34) days | 0.586 |
Hospitalized within 30 days, n (%) | ||||
No | 113 (97.4) | 67 (100) | 46 (93.6) | - |
Yes | 3 (2.6) | 0 (0) | 3 (6.1) | 0.073 |
Cause of first hospitalization | ||||
Variceal bleeding, n (%) | ||||
No | 74 (63.8) | 43 (64.2) | 31 (63.3) | - |
Yes | 42 (36.2) | 24 (35.8) | 18 (36.7) | 1.000 |
Jaundice, n (%) | ||||
No | 88 (75.9) | 62 (92.5) | 26 (53.1) | - |
Yes | 28 (24.1) | 5 (7.5) | 23 (46.9) | < 0.001 |
Hepatic encephalopathy, n (%) | ||||
No | 72 (62.1) | 54 (80.6) | 18 (36.7) | - |
Grade 1–2 | 19 (16.4) | 7 (10.4) | 12 (24.5) | 0.003 |
Grade 3–4 | 25 (21.6) | 6 (9.0) | 19 (38.8) | < 0.001 |
Ascites, n (%) | ||||
No | 66 (56.9) | 50 (74.6) | 16 (32.7) | - |
Mild | 6 (5.2) | 4 (6.0) | 2 (4.1) | 0.625 |
Massive | 44 (37.9) | 13 (19.4) | 31 (63.3) | < 0.001 |